Invest in Marijuana 

Welcome to InvestInMarijuana.com.au, internationally cannabis has hit the headlines in a major fashion over the past few years and it is due to relatively unknown recent scientific discoveries which have the potential to revolutionize health care worldwide for humans and for their pets.  This key discovery is that humans have an Endocannabinoid System (ECS) which responds to cannabis and the ECS is responsible for maintaining good health. Research is indicating that the cannabinoids found in cannabis may one day soon be more prevalent that vitamin C and will be in all forms of products ranging from foods to cosmetics.

The Endocannabinoid System and Investing in Marijuana

In addition, the prescription opioid epidemic sweeping the world sees an estimated 26-36 million people abusing prescription opioids. Research reveals that cannabis is helping patients deal with ailments without the addictive aspects of opioids. This massive surge in demand for cannabis based products indicates that the market may become a US$500 billion industry and in the short term will reach US$146.4 billion by end of 2025. 

Medicinal Organic Cannabis Australia (MOCA) entered this market in 2017 with the view to become a global leader in the production and distribution of medical cannabis products and since that time has worked to position itself as an industry leader. The company has obtained Australian importation and exportation licences and has partnered with industry leaders to provide premium organic cannabis. based medication. 

The company has made strategic partnerships which enable MOCA to leverage dozens of other premium digital assets to sell to an international audience. It now seeks a suitable logistics partner with significant scalability properties to assist with its objectives of supporting cultivation and distribution. 

Much news and discussion has evolved in recent decades regarding the role of marijuana in both the medical and recreational market. Medical marijuana has featured strongly as an alternative source of natural well-being around the world with nations such as Canada, Israel and Uruguay opening up to medicinal cannabis industries. International growth and interest in the marijuana industry has been nothing short of spectacular over the past couple of years with the legal cannabis market estimated to reach $50 billion in the U.S. alone by 2026. 

Invest in Marijuana in Australia with MOCA

Marijuana Investment Opportunities in Australia

In October 2016, the Australian government legislated to make provisions for the legal cultivation of medicinal cannabis. With this change in legislation, Australia entered into the global marketplace alongside countries such as Italy, Israel, Canada, United States and many others which have legislated to make available medicinal cannabis.

Medicinal Organic Cannabis Australia (MOCA)  is committed to promoting and developing the industry with its eye firmly focused on the explosive international market. 

Research indicates that the cannabis products have beneficial properties for a series of medical conditions and symptoms including pain, epilepsy, and a number of other clinical conditions. With the birth of this industry, in Australia, opportunities abound investment to produce organic clinically proven medical cannabis. Medicinal Organic Cannabis Australia (MOCA) is positioning to become a producer, cultivator and promoter of the Marijuana industry in Australia and internationally.

The key strengths of the company are its powerful internet presence – the long vision of its founders on promoting the products in an industry where the race is to become cultivators of the plant. On that subject, MOCA has embraced an innovative and eco-friendly strategy to cultivate medical and recreational cannabis both for an Australian and international market. 

Invest In Marijuana Industry in Australia and New Zealand

Investing in Cannabis in Australia with MOCA offers the opportunity to be at the forefront of this global industry. MOCA is an Australian Company which holds licences at a State and Federal level in Australia under the Australian Government’s new medical cannabis regulatory system and is currently seeking licences from the government to undertake research, importation, production and to cultivate cannabis for human medicinal purposes in New Zealand. 

MOCA is seeking to raise investment to build and develop various aspects of its commercial enterprise including construction of a pharmaceutical grade cultivation and extraction facility. 
MOCA’s points of differentiation include the use of indoor cultivation in controlled environments, utilizing aquaponic systems designed to create medicinal organic cannabis products for local and international market supply.
Key to MOCA's points of differentiation is the agreement with New Realm to leverage its strategic digital platform to market organic products in Australia, New Zealand and internationally.